Insightful analysis and commentary for the US and global equity investor
Contributors: Douglas McIntyre Jon C. Ogg

Previous Posts

Wednesday, October 18, 2006

IPO Pricing: Trubion Pharmaceuticals (TRBN)

Trubion Pharmaceuticals (TRBN) priced its 4 million share IPO at $13.00, which is at the lower-end of the 413.00 to $15.00 range.

Trubion is a Seattle, WA-based development stage biotech in the quest to treat rheumatoid arthritis and systemic lupus. More can be found at website.

Morgan Stanley is the lead underwriter; and co-managers are listed as Bank of America, Pacific Growth, and Lazard.

Jon C. Ogg
October 18, 2006

Powered by Blogger